83 results on '"Grossman, Ashley"'
Search Results
2. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
3. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
4. Craniopharyngiomas and proton beam therapy: worth the expense?
5. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance
6. Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly
7. Thought for food: a Cushing's syndrome enigma explained
8. Consensus on diagnosis and management of Cushing's disease: a guideline update
9. Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline
10. Editorial overview: Neuroendocrine tumours
11. COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
12. Paraneoplastic hypoglycaemia secondary to IGF-2 secretion from a metastatic gastrointestinal stromal tumour
13. The tumour microenvironment of pituitary neuroendocrine tumours
14. Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
15. Endocrinological Toxicity Secondary to Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
16. Pheochromocytoma: An approach to diagnosis
17. The sinister side of Cushing's therapy
18. NET-Working for the Future
19. Innovations in the Management of Neuroendocrine Tumors
20. The Ectopic Adrenocorticotropic Hormone Syndrome
21. Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies
22. Initiation of Patients onto Long-Acting Somatostatin Analogue Therapy for Neuroendocrine Tumors: A Single-Center Review of Practice
23. Is the new treatment for Cushing's disease too sweet?
24. Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction
25. Somatic and germline mutations in NETs: Implications for their diagnosis and management
26. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
27. SDHC Mutations are Associated with Cardiac Paragangliomas: A Case Report of a Patient With a Dopamine-Secreting Tumor and Review of the Literature
28. A Patient with an Apparently Sporadic Pheochromocytoma with a Rearranged During Transfection Codon 635 Variant: A Mild Form of Multiple Endocrine Neoplasia Type 2?
29. An unusual primary biphasic neuroendocrine carcinoma of lung associated with ectopic ACTH production and Cushing's syndrome
30. The nuclear option for insulinomas
31. Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Advanced Lung Neuroendocrine Tumors
32. Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
33. Differential Diagnosis of Adrenocorticotropic Hormone-Independent Cushing Syndrome: Role of Adrenal Venous Sampling
34. Cushing Syndrome Secondary to A Thymic Carcinoid Tumor Due to Multiple Endocrine Neoplasia Type 1
35. Multiglandular Parathyroid Carcinoma: Case Report and Review of The Literature
36. Androgen- and Estrogen-Secreting Adrenal Cancers
37. Cyclins and their related proteins in pituitary tumourigenesis
38. Phase-3 randomized trial of everolimus (RAD001) vs. placebo in advanced pancreatic NET (RADIANT-3)
39. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA)
40. Where metabolism meets oncogenesis: another false lead?
41. A Single-Center Open-Label Study To Investigate The Efficacy And Safety Of Repeated Subcutaneous Injections Of Lanreotide Autogel In Patients With Acromegaly Previously Treated With Octreotide
42. The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt–mTOR–p70S6K pathway in human medullary thyroid carcinoma cells
43. Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer
44. The pathophysiology of pituitary adenomas
45. The role of somatostatin analogues in the treatment of neuroendocrine tumours
46. Endocrine manifestations in Langerhans cell histiocytosis
47. Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances
48. Medical training in the UK: sleepwalking to disaster
49. Modernising Medical Careers, Medical Training Application Service, and the Postgraduate Medical Education and Training Board: time for the emperors to don their clothes
50. Expanding role of AMPK in endocrinology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.